Mitochondrial Respiratory Chain Enzyme Activities, mtDNA Variants and Gene Expression Levels in Idiopathic Parkinson's Disease

被引:0
作者
Ercan, Ayse [2 ]
Kulaksiz, Gulnihal [1 ]
Dalmizrak, Ozlem [1 ,3 ]
Muftuoglu, Meltem [1 ]
Ogus, Hamdi [1 ]
Cavdar, Leyla [4 ]
Inan, Levent [4 ]
Ozer, Nazmi [1 ,3 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Biochem, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Fac Pharm, Dept Biochem, TR-06100 Ankara, Turkey
[3] Near East Univ, Fac Med, Dept Basic Med Sci, TR-10 Nicosia, Mersin, Turkey
[4] Ankara Res & Training Hosp, Dept Neurol, TR-06100 Ankara, Turkey
来源
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI | 2009年 / 34卷 / 02期
关键词
Idiopathic PD; Complex I; glutathione; ND2; ND4; COMPLEX-I ACTIVITY; SKELETAL-MUSCLE; GLUTATHIONE DEPLETION; DNA; DYSFUNCTION; INHIBITION; MUTATIONS; PLATELETS; BRAIN;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose: Mitochondrial dysfunction has been implicated in the development of idiopathic Parkinson's disease. In this study, it was aimed to investigate the relationship between mitochondrial respiratory chain enzyme deficiency and variants in ND2 and ND4 region of Complex I and expressions of these genes. Complex IV activity and glutathione level were also studied. Methods: Activities of Complex I, Complex IV, citrate synthase and glutathione levels were measured from muscle biopsy samples of 19 idiopathic Parkinson's Disease patients. Entire ND2 and ND4 regions of Complex I were screened by sequencing and expression levels of these regions were also examined by using relative quantitative RT-PCR. Results: A significant decrease in Complex I and IV activities was found in Parkinson's Disease patients (19.73 +/- 8.24 U/mg protein, 11.51 +/- 6.45 U/mg protein) compared with the control group (31.48 +/- 8.28 U/mg protein, 30.02 +/- 14.76 U/mg protein), respectively. Although several sequence variants were detected in ND2 and ND4 genes, they didn't account for the decrease in Complex I activity. ND2 (19 % and 21 %) and ND4 (14 % and 13 %) mRNA expressions were reduced in two of 19 patients. Conclusion: Taken together, Complex I and IV dysfunctions and mitochondrial abnormalities might be the result of oxidative stress contributing to the pathogenesis of idiopathic Parkinson's Disease since we found that reduced glutathione levels were decreased 47 % in these patients.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 50 条
  • [31] Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis
    Burbulla, Lena F.
    Schelling, Carina
    Kato, Hiroki
    Rapaport, Doron
    Woitalla, Dirk
    Schiesling, Carola
    Schulte, Claudia
    Sharma, Manu
    Illig, Thomas
    Bauer, Peter
    Jung, Stephan
    Nordheim, Alfred
    Schoels, Ludger
    Riess, Olaf
    Krueger, Rejko
    HUMAN MOLECULAR GENETICS, 2010, 19 (22) : 4437 - 4452
  • [32] Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease
    Wang, Gang
    Huang, Yue
    Chen, Wei
    Chen, Shuai
    Wang, Ying
    Xiao, Qin
    Liu, Jun
    Fung, Victor S. C.
    Halliday, Glenda
    Chen, Shengdi
    PARKINSONISM & RELATED DISORDERS, 2016, 24 : 89 - 94
  • [33] Evaluation of PARKIN gene variants in West Bengal Parkinson's disease patients
    Sanyal, Jaya
    Jana, Arpita
    Ghosh, Epsita
    Banerjee, Tapas K.
    Chakraborty, Durga P.
    Rao, Vadlamudi R.
    JOURNAL OF HUMAN GENETICS, 2015, 60 (09) : 485 - 492
  • [34] Extended Study of NUS1 Gene Variants in Parkinson's Disease
    Yuan, Lamei
    Chen, Xiangyu
    Song, Zhi
    Le, Weidong
    Zheng, Wen
    Liu, Xin
    Deng, Hao
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [35] PARK2 gene variants in Korean patients with Parkinson's disease
    Park, Min-young
    Park, In won
    Ihm, Chun Hwa
    Kim, Eunhee
    GENES & GENOMICS, 2016, 38 (02) : 163 - 169
  • [36] Identification of Disease-Associated Variants by Targeted Gene Panel Resequencing in Parkinson's Disease
    Daida, Kensuke
    Funayama, Manabu
    Li, Yuanzhe
    Yoshino, Hiroyo
    Hayashida, Arisa
    Ikeda, Aya
    Ogaki, Kotaro
    Nishioka, Kenya
    Hattori, Nobutaka
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [37] Common gene expression signatures in Parkinson's disease are driven by changes in cell composition
    Nido, Gonzalo S.
    Dick, Fiona
    Toker, Lilah
    Petersen, Kjell
    Alves, Guido
    Tysnes, Ole-Bjorn
    Jonassen, Inge
    Haugarvoll, Kristoffer
    Tzoulis, Charalampos
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2020, 8 (01)
  • [38] Decreased Expression of Lysosomal Alpha-Galactosiase A Gene in Sporadic Parkinson's Disease
    Wu, Guanghua
    Huang, Jian
    Feng, Xungang
    Zhang, Aimei
    Li, Jifeng
    Pang, Shuchao
    Gu, Kejin
    Dong, Haixin
    Zhang, Junping
    Gao, Huijie
    Yan, Bo
    NEUROCHEMICAL RESEARCH, 2011, 36 (10) : 1939 - 1944
  • [39] Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics
    Irrcher, I.
    Aleyasin, H.
    Seifert, E. L.
    Hewitt, S. J.
    Chhabra, S.
    Phillips, M.
    Lutz, A. K.
    Rousseaux, M. W. C.
    Bevilacqua, L.
    Jahani-Asl, A.
    Callaghan, S.
    MacLaurin, J. G.
    Winklhofer, K. F.
    Rizzu, P.
    Rippstein, P.
    Kim, R. H.
    Chen, C. X.
    Fon, E. A.
    Slack, R. S.
    Harper, M. E.
    McBride, H. M.
    Mak, T. W.
    Park, D. S.
    HUMAN MOLECULAR GENETICS, 2010, 19 (19) : 3734 - 3746
  • [40] Mitochondrial DNA in CSF distinguishes LRRK2 from idiopathic Parkinson's disease
    Podlesniy, Petar
    Vilas, Dolores
    Taylor, Peggy
    Shaw, Leslie M.
    Tolosa, Eduard
    Trullas, Ramon
    NEUROBIOLOGY OF DISEASE, 2016, 94 : 10 - 17